Natera Operating Cash Flow 2011-2026 | NTRA

Annual Operating Cash Flow Natera

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-432 M	-335 M	-183 M	-63.4 M	-70.6 M	-97.8 M	-74.1 M	-37.8 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-37.8 M	-432 M	-162 M

Quarterly Operating Cash Flow Natera

2024-Q3	2023-Q4	2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-137 M	-	-	-	-74.9 M	-	-109 M	-76.1 M	-35.1 M	-	-48.4 M	-35.8 M	-31.8 M	-	-57.8 M	-34.5 M	1.05 M	-	-69.7 M	-38.4 M	-24.6 M	-	-44.4 M	-20.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.05 M	-137 M	-52.3 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.48 B	$ 113.86	-0.85 %	$ 34.6 B	USA
Danaher Corporation DHR	6.42 B	$ 190.59	-0.8 %	$ 136 B	USA
DexCom DXCM	1.44 B	$ 63.64	0.68 %	$ 24.8 B	USA
Fulgent Genetics FLGT	21.1 M	$ 16.32	-0.61 %	$ 493 M	USA
Guardant Health GH	-185 M	$ 90.59	1.04 %	$ 11.4 B	USA
ICON Public Limited Company ICLR	1.29 B	$ 107.81	-1.66 %	$ 8.89 B	Irlanda
Illumina ILMN	837 M	$ 127.23	-0.4 %	$ 20.2 B	USA
CareDx, Inc CDNA	42 M	$ 17.63	-1.07 %	$ 939 M	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 274.85	0.14 %	$ 22.9 B	USA
Lantheus Holdings LNTH	390 M	$ 75.68	-0.28 %	$ 5.11 B	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Medpace Holdings MEDP	713 M	$ 493.63	-0.48 %	$ 14.2 B	USA
Burning Rock Biotech Limited BNR	-478 M	$ 16.99	4.23 %	$ 176 M	China
Myriad Genetics MYGN	1.8 M	$ 4.62	-1.07 %	$ 428 M	USA
Co-Diagnostics CODX	-29.1 M	$ 4.4	101.83 %	$ 5.85 M	USA
NeoGenomics NEO	5.23 M	$ 7.98	-0.5 %	$ 1.02 B	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Neogen Corporation NEOG	58.2 M	$ 9.93	3.82 %	$ 2.15 B	USA
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
National Research Corporation NRC	26.4 M	$ 17.24	-0.52 %	$ 386 M	USA
Pacific Biosciences of California PACB	-111 M	$ 1.4	-1.76 %	$ 420 M	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Precipio PRPO	685 K	$ 26.0	0.08 %	$ 41.7 M	USA
Personalis PSNL	-45.2 M	$ 6.21	-5.57 %	$ 368 M	USA
Charles River Laboratories International CRL	738 M	$ 167.8	-0.25 %	$ 8.32 B	USA
Sotera Health Company SHC	287 M	$ 14.86	-0.1 %	$ 4.22 B	USA
Castle Biosciences CSTL	64.9 M	$ 24.96	0.93 %	$ 693 M	USA
Soleno Therapeutics SLNO	46.8 M	$ 52.25	-	$ 2.66 B	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Neuronetics STIM	-20.4 M	$ 1.6	-9.09 %	$ 106 M	USA
Biodesix BDSX	-48.6 M	$ 14.71	-4.21 %	$ 1.91 B	USA
Thermo Fisher Scientific TMO	7.82 B	$ 483.56	-0.95 %	$ 182 B	USA
Trinity Biotech plc TRIB	13.2 M	$ 0.61	-1.34 %	$ 61.9 M	Irlanda
VolitionRx Limited VNRX	-19.7 M	$ 0.17	-0.89 %	$ 21.4 M	Singapore
Waters Corporation WAT	653 M	$ 301.9	-0.72 %	$ 18 B	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	-7.17 M	$ 2.59	-	$ 84.1 K	USA
Biomerica BMRA	-3.84 M	$ 2.08	-4.13 %	$ 4.78 M	USA
BioNano Genomics BNGO	-16.3 M	$ 1.14	-1.3 %	$ 6.21 M	USA
Interpace Biosciences IDXG	5.83 M	$ 2.02	2.54 %	$ 8.94 M	USA
Check-Cap Ltd. CHEK	-8 M	-	-	$ 9.42 M	Israel
Celcuity CELC	-153 M	$ 113.87	-0.31 %	$ 5.32 B	USA